Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $33,922 | 4 | 99.0% |
| Food and Beverage | $351.32 | 4 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CSL Behring | $13,930 | 2 | $0 (2021) |
| Mallinckrodt Hospital Products Inc. | $10,400 | 1 | $0 (2020) |
| Janssen Research & Development, LLC | $9,669 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $151.16 | 1 | $0 (2018) |
| PFIZER INC. | $123.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $47.50 | 1 | Janssen Research & Development, LLC ($47.50) |
| 2022 | $29.66 | 1 | Janssen Research & Development, LLC ($29.66) |
| 2021 | $13,930 | 2 | CSL Behring ($13,930) |
| 2020 | $19,992 | 2 | Mallinckrodt Hospital Products Inc. ($10,400) |
| 2019 | $123.00 | 1 | PFIZER INC. ($123.00) |
| 2018 | $151.16 | 1 | E.R. Squibb & Sons, L.L.C. ($151.16) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/26/2023 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $47.50 | General |
| 04/02/2022 | Janssen Research & Development, LLC | XARELTO (Drug) | Food and Beverage | In-kind items and services | $29.66 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/26/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $6,965.00 | General |
| 10/18/2021 | CSL Behring | — | Consulting Fee | Cash or cash equivalent | $6,965.00 | General |
| 12/21/2020 | Janssen Research & Development, LLC | XARELTO (Drug) | Consulting Fee | Cash or cash equivalent | $9,592.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/21/2020 | Mallinckrodt Hospital Products Inc. | — | Consulting Fee | Cash or cash equivalent | $10,400.00 | General |
| 03/16/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/10/2018 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $151.16 | General |
About Peter Dibattiste
Peter Dibattiste is a Cardiovascular Disease healthcare provider based in Doylestown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/26/2011. The National Provider Identifier (NPI) number assigned to this provider is 1164799755.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Dibattiste has received a total of $34,273 in payments from pharmaceutical and medical device companies, with $47.50 received in 2023. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($33,922).
Practice Information
- Specialty Cardiovascular Disease
- Location Doylestown, PA
- Active Since 11/26/2011
- Last Updated 11/26/2011
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164799755
Products in Payments
- XARELTO (Drug) $9,622
- VYNDAQEL (Drug) $123.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Doylestown
Dr. Stephen Sloan, Md, Facc, MD, FACC
Cardiovascular Disease — Payments: $105,730
Dr. James Kmetzo, M.d, Facc, M.D, FACC
Cardiovascular Disease — Payments: $84,870
Dr. Robert Sangrigoli, Md, MD
Cardiovascular Disease — Payments: $67,308
Philip Wiener, D.o, D.O
Cardiovascular Disease — Payments: $60,970
John Harding, M.d, M.D
Cardiovascular Disease — Payments: $45,223
Irfan Khurram, M.d, M.D
Cardiovascular Disease — Payments: $37,511